Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0002262 | myeloid cell homeostasis | 29/1618 | 147/18670 | 0.0000214 | 0.002963 | 0.002582 | 29 | RABC14 | |
BP | GO:0044783 | G1 DNA damage checkpoint | 17/1618 | 64/18670 | 0.0000216 | 0.002963 | 0.002582 | 17 | RABC14 | |
BP | GO:0031570 | DNA integrity checkpoint | 30/1618 | 157/18670 | 0.0000295 | 0.003923 | 0.003418 | 30 | RABC14 | |
BP | GO:0038034 | signal transduction in absence of ligand | 18/1618 | 72/18670 | 0.0000306 | 0.003923 | 0.003418 | 18 | RABC14 | |
BP | GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 18/1618 | 72/18670 | 0.0000306 | 0.003923 | 0.003418 | 18 | RABC14 | |
BP | GO:0007050 | cell cycle arrest | 40/1618 | 237/18670 | 0.0000331 | 0.004075 | 0.003551 | 40 | RABC14 | |
BP | GO:0002576 | platelet degranulation | 26/1618 | 128/18670 | 0.0000332 | 0.004075 | 0.003551 | 26 | RABC14 | |
BP | GO:0140014 | mitotic nuclear division | 43/1618 | 264/18670 | 0.0000411 | 0.00495 | 0.004313 | 43 | RABC14 | |
BP | GO:0097191 | extrinsic apoptotic signaling pathway | 38/1618 | 224/18670 | 0.000046 | 0.005381 | 0.004689 | 38 | RABC14 | |
BP | GO:0042744 | hydrogen peroxide catabolic process | 11/1618 | 32/18670 | 0.0000466 | 0.005381 | 0.004689 | 11 | RABC14 | |
BP | GO:0098810 | neurotransmitter reuptake | 10/1618 | 27/18670 | 0.0000495 | 0.005613 | 0.004891 | 10 | RABC14 | |
BP | GO:0014013 | regulation of gliogenesis | 25/1618 | 124/18670 | 0.0000531 | 0.005907 | 0.005148 | 25 | RABC14 | |
BP | GO:1903707 | negative regulation of hemopoiesis | 29/1618 | 155/18670 | 0.0000594 | 0.006489 | 0.005654 | 29 | RABC14 | |
BP | GO:0048821 | erythrocyte development | 11/1618 | 33/18670 | 0.0000644 | 0.006832 | 0.005954 | 11 | RABC14 | |
BP | GO:0070942 | neutrophil mediated cytotoxicity | 6/1618 | 10/18670 | 0.0000649 | 0.006832 | 0.005954 | 6 | RABC14 | |
BP | GO:0051098 | regulation of binding | 55/1618 | 373/18670 | 0.0000675 | 0.006984 | 0.006086 | 55 | RABC14 | |
BP | GO:0044773 | mitotic DNA damage checkpoint | 21/1618 | 97/18670 | 0.0000702 | 0.007139 | 0.006221 | 21 | RABC14 | |
BP | GO:0051852 | disruption by host of symbiont cells | 7/1618 | 14/18670 | 0.000072 | 0.007196 | 0.00627 | 7 | RABC14 | |
BP | GO:0003279 | cardiac septum development | 23/1618 | 112/18670 | 0.0000774 | 0.007606 | 0.006628 | 23 | RABC14 | |
BP | GO:0007009 | plasma membrane organization | 22/1618 | 105/18670 | 0.0000803 | 0.007723 | 0.00673 | 22 | RABC14 | |
BP | GO:0001933 | negative regulation of protein phosphorylation | 61/1618 | 429/18670 | 0.0000812 | 0.007723 | 0.00673 | 61 | RABC14 | |
BP | GO:0090068 | positive regulation of cell cycle process | 46/1618 | 298/18670 | 0.0000869 | 0.008128 | 0.007083 | 46 | RABC14 | |
BP | GO:0000070 | mitotic sister chromatid segregation | 28/1618 | 151/18670 | 0.000093 | 0.008445 | 0.007359 | 28 | RABC14 | |
BP | GO:0044774 | mitotic DNA integrity checkpoint | 22/1618 | 106/18670 | 0.0000931 | 0.008445 | 0.007359 | 22 | RABC14 | |
BP | GO:0002237 | response to molecule of bacterial origin | 51/1618 | 343/18670 | 0.0000987 | 0.008819 | 0.007685 | 51 | RABC14 | |
BP | GO:0003181 | atrioventricular valve morphogenesis | 9/1618 | 24/18670 | 0.000106 | 0.009323 | 0.008124 | 9 | RABC14 | |
BP | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 22/1618 | 107/18670 | 0.0001078 | 0.009343 | 0.008142 | 22 | RABC14 | |
BP | GO:0000077 | DNA damage checkpoint | 27/1618 | 145/18670 | 0.0001144 | 0.009708 | 0.008459 | 27 | RABC14 | |
BP | GO:0007411 | axon guidance | 43/1618 | 276/18670 | 0.0001176 | 0.009708 | 0.008459 | 43 | RABC14 | |
BP | GO:0030168 | platelet activation | 28/1618 | 153/18670 | 0.0001178 | 0.009708 | 0.008459 | 28 | RABC14 |